IP 9 Pill — GREEN ROUND, 10mm — Alprazolam

No photo available

Imprint	IP / 9
Colour	GREEN
Shape	ROUND
Size	10
Strength	ALPRAZOLAM 0.5 mg
Dosage form	Tablet, Extended Release
Manufacturer	Rebel Distributors Corp
NDC	21695-602
Schedule	—
Availability	—
Ingredients	ALPRAZOLAM[ALPRAZOLAM]

What does this imprint mean?

The imprint "IP 9" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Alprazolam

Uses and warnings

Key warnings include: - Dependence/Withdrawal: "Certain adverse clinical events, some life-threatening, are a direct consequence of physical dependence." Even at recommended doses, dependence risk exists; risk increases above 4 mg/day. Seizures can occur during discontinuation. - CNS Depression: Patients should avoid "hazardous occupations or activities requiring complete mental alertness such as operating machinery or driving." - Pregnancy: Benzodiazepines "potentially cause fetal harm when administered to pregnant women"; avoid during first trimester. - CYP3A Interactions: Contraindicated with ketoconazole and itraconazole due to dangerous metabolic interactions. ---

Alprazolam tablets treat two primary conditions: Anxiety Disorders: "management of anxiety disorder" corresponding to generalized anxiety disorder, or "short-term relief of symptoms of anxiety." The label specifies that everyday stress-related anxiety typically doesn't warrant treatment. Panic Disorder: "treatment of panic disorder, with or without agoraphobia." Clinical studies demonstrated effectiveness over 4-10 weeks, though some patients received treatment up to 8 months without apparent loss of benefit. ---

Read the full drug profile →

How to identify this pill

• Check the imprint matches exactly: "IP 9".
• Confirm the colour (GREEN) and shape (ROUND).
• Compare the size (10) against a ruler if possible.
• When in doubt, confirm with a pharmacist before taking any medication.

Similar-looking pills

CIBA 3

GREEN ROUND · Methylphenidate